http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1825851-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6890b1f2727fc82ce15bcad3cbd7d1ff
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-35
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-535
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-352
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-137
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-535
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-35
filingDate 2000-06-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d6dcd4507b97e6676ba1757866d348ab
publicationDate 2011-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-1825851-A3
titleOfInvention Combination therapy for effecting weight loss and treating obesity
abstract The present invention features a novel therapy for effecting weight loss which involves treating a subject with a sympathomimetic agent (e.g. phentermine or a phentermine-like drug) in combination with an anticonvulsant sulfamate derivative (e.g., topiramate) such that the subject experiences weight loss. The combination methods of the present invention also are effective against symptoms associates with Syndrome X. The invention also features pharmaceutical compositions and kits for use in the practice of these novel therapies.
priorityDate 1999-06-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419535122
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128389335
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5284627
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507197
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127734846
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID177700
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414671614
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226421065
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4771
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226414425

Total number of triples: 27.